134 related articles for article (PubMed ID: 8063280)
21. An animal model for Epstein-Barr virus (EBV)-associated lymphomagenesis in the human: malignant lymphoma induction of rabbits by EBV-related herpesvirus from cynomolgus.
Hayashi K; Akagi T
Pathol Int; 2000 Feb; 50(2):85-97. PubMed ID: 10792766
[TBL] [Abstract][Full Text] [Related]
22. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
[TBL] [Abstract][Full Text] [Related]
23. Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus.
Lam KY; Lo CY; Kwong DL; Lee J; Srivastava G
Am J Clin Pathol; 1999 Aug; 112(2):263-70. PubMed ID: 10439808
[TBL] [Abstract][Full Text] [Related]
24. Malignant lymphoma induction of rabbits with oral spray of Epstein-Barr virus-related herpesvirus from Si-IIA cells (HTLV-II-transformed Cynomolgus cell line): a possible animal model for Epstein-Barr virus infection and subsequent virus-related tumors in humans.
Koirala TR; Hayashi K; Chen HL; Ino H; Kariya N; Yanai H; Choudhury CR; Akagi T
Pathol Int; 1997 Jul; 47(7):442-8. PubMed ID: 9234382
[TBL] [Abstract][Full Text] [Related]
25. Incidence of Epstein-Barr virus in AIDS-related lymphoma specimens.
Samoszuk M; Nguyen V; Shadan FF; Ramzi E
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):913-8. PubMed ID: 8391077
[TBL] [Abstract][Full Text] [Related]
26. Sporadic activation of Epstein-Barr virus in thyroid lymphoma.
Tomita Y; Ohsawa M; Kanno H; Matsuzuka F; Kuma K; Aozasa K
Leuk Lymphoma; 1995 Sep; 19(1-2):129-34. PubMed ID: 8574157
[TBL] [Abstract][Full Text] [Related]
27. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
[TBL] [Abstract][Full Text] [Related]
28. No significant role of Epstein-Barr virus in the tumorigenesis of Warthin tumor.
Ogata T; Hongfang Y; Kayano T; Hirai K
J Med Dent Sci; 1997 Jun; 44(2):45-52. PubMed ID: 9608281
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in nonimmunocompromised patients.
Sabourin JC; Kanavaros P; Briere J; Lescs MC; Petrella T; Zafrani ES; Gaulard P
Am J Surg Pathol; 1993 Oct; 17(10):995-1002. PubMed ID: 8396858
[TBL] [Abstract][Full Text] [Related]
30. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma.
Nicholson AG; Wotherspoon AC; Diss TC; Singh N; Butcher DN; Pan LX; Isaacson PG; Corrin B
Histopathology; 1996 Oct; 29(4):317-24. PubMed ID: 8910039
[TBL] [Abstract][Full Text] [Related]
31. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review.
Anagnostopoulos I; Hummel M; Stein H
Leuk Lymphoma; 1995 Sep; 19(1-2):1-12. PubMed ID: 8574154
[TBL] [Abstract][Full Text] [Related]
32. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
33. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A
Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome.
Pflugfelder SC; Crouse CA; Monroy D; Yen M; Rowe M; Atherton SS
Am J Pathol; 1993 Jul; 143(1):49-64. PubMed ID: 8391219
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
36. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection.
Barletta JM; Kingma DW; Ling Y; Charache P; Mann RB; Ambinder RF
Mol Cell Probes; 1993 Apr; 7(2):105-9. PubMed ID: 8391639
[TBL] [Abstract][Full Text] [Related]
37. Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease.
Armstrong AA; Weiss LM; Gallagher A; Jones DB; Krajewski AS; Angus B; Brown G; Jack AS; Wilkins BS; Onions DE
Leukemia; 1992 Sep; 6(9):869-74. PubMed ID: 1325580
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease.
Khan G; Naase MA
J Clin Pathol; 1995 Sep; 48(9):845-8. PubMed ID: 7490319
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus infection in HIV-positive patients.
Telenti A; Uehlinger DE; Marchesi F; Germann D; Malinverni R; Matter L
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):601-9. PubMed ID: 7901016
[TBL] [Abstract][Full Text] [Related]
40. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas.
Murray PG; Niedobitek G; Kremmer E; Grässer F; Reynolds GM; Cruchley A; Williams DM; Müller-Lantzsch N; Young LS
J Pathol; 1996 Jan; 178(1):44-7. PubMed ID: 8778314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
